Polyomaviridae

Quality 0.50 · 0 views · Updated 2 months ago

Family of viruses

title: "Polyomaviridae" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["polyomaviridae", "infectious-causes-of-cancer", "virus-families"] description: "Family of viruses" topic_path: "general/polyomaviridae" source: "https://en.wikipedia.org/wiki/Polyomaviridae" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0

::summary Family of viruses ::

| taxon = Polyomaviridae | image = Polyomavirus.jpg | image_caption = Micrograph showing a polyomavirus infected cell—large (blue) cell below-center-left. Urine cytology specimen. | subdivision_ranks = Genera | subdivision = See text

Polyomaviridae is a family of DNA viruses whose natural hosts are mammals and birds. As of 2024, there are eight recognized genera. Fourteen species are known to infect humans, while others, such as Simian Virus 40, have been identified in humans to a lesser extent. Most of these viruses are very common and typically asymptomatic in most human populations studied. BK virus is associated with nephropathy in renal transplant and non-renal solid organ transplant patients, JC virus with progressive multifocal leukoencephalopathy, and Merkel cell virus with Merkel cell cancer.

Structure and genome

::figure[src="https://upload.wikimedia.org/wikipedia/commons/9/97/Mpyv_colorbydepth.png" caption="1SIE}}."] ::

Polyomaviruses are non-enveloped double-stranded DNA viruses with circular genomes of around 5000 base pairs. With such a small size, they are ranked among the smallest known double stranded DNA viruses. The genome is packaged in a viral capsid of about 40-50 nanometers in diameter, which is icosahedral in shape (T=7 symmetry). The capsid is composed of 72 pentameric capsomeres of a protein called VP1, which is capable of self-assembly into a closed icosahedron; each pentamer of VP1 is associated with one molecule of one of the other two capsid proteins, VP2 or VP3. ::figure[src="https://upload.wikimedia.org/wikipedia/commons/3/38/Gaynor_plospathogens_2007_WUvirusgenome.png" caption="doi-access = free }}"] ::

The genome of a typical polyomavirus codes for between five and nine proteins, divided into two transcriptional regions called the early and late regions due to the time during infection in which they are transcribed. Each region is transcribed by the host cell's RNA polymerase II as a single pre-messenger RNA containing multiple genes. The early region usually codes for two proteins, the small and large tumor antigens, produced by alternative splicing. The late region contains the three capsid structural proteins VP1, VP2, and VP3, produced by alternative translational start sites. Additional genes and other variations on this theme are present in some viruses: for example, rodent polyomaviruses have a third protein called middle tumor antigen in the early region, which is extremely efficient at inducing cellular transformation; SV40 has an additional capsid protein VP4; some examples have an additional regulatory protein called agnoprotein expressed from the late region. The genome also contains a non-coding control or regulatory region containing the early and late regions' promoters, transcriptional start sites, and the origin of replication.

Replication and life cycle

::figure[src="https://upload.wikimedia.org/wikipedia/commons/d/da/Mpyv_vp1_gt1a_5cpw.png" caption="5CPW}}."] ::

The polyomavirus life cycle begins with entry into a host cell. Cellular receptors for polyomaviruses are sialic acid residues of glycans, commonly gangliosides. The attachment of polyomaviruses to host cells is mediated by the binding of VP1 to sialylated glycans on the cell surface. In some particular viruses, additional cell-surface interactions occur; for example, the JC virus is believed to require interaction with the 5HT2A receptor and the Merkel cell virus with heparan sulfate. However, in general virus-cell interactions are mediated by commonly occurring molecules on the cell surface, and therefore are likely not a major contributor to individual viruses' observed cell-type tropism. – where the viral capsid structure is likely to be disrupted by action of host cell disulfide isomerase enzymes.

The details of transit to the nucleus are not clear and may vary among individual polyomaviruses. It has been frequently reported that an intact, albeit distorted, virion particle is released from the endoplasmic reticulum into the cell cytoplasm, where the genome is released from the capsid, possibly due to the low calcium concentration in the cytoplasm. LT induces DNA replication from the viral genome's non-coding control region (NCCR), after which expression of the early mRNA is reduced and expression of the late mRNA, which encodes the viral capsid proteins, begins. Several mechanisms have been described for regulating the transition from early to late gene expression, including the involvement of the LT protein in repressing the early promoter, the expression of un-terminated late mRNAs with extensions complementary to early mRNA, and the expression of regulatory microRNA. Expression of the late genes results in accumulation of the viral capsid proteins in the host cell cytoplasm. Capsid components enter the nucleus in order to encapsidate new viral genomic DNA. New virions may be assembled in viral factories. The mechanism of viral release from the host cell varies among polyomaviruses; some express proteins that facilitate cell exit, such as the agnoprotein or VP4. In some cases high levels of encapsidated virus result in cell lysis, releasing the virions.

Viral proteins

Tumor antigens

The large tumor antigen plays a key role in regulating the viral life cycle by binding to the viral origin of DNA replication where it promotes DNA synthesis. Also as the polyomavirus relies on the host cell machinery to replicate the host cell needs to be in s-phase for this to begin. Due to this, large T-antigen also modulates cellular signaling pathways to stimulate progression of the cell cycle by binding to a number of cellular control proteins. This is achieved by a two prong attack of inhibiting tumor suppressing genes p53 and members of the retinoblastoma (pRB) family, and stimulating cell growth pathways by binding cellular DNA, ATPase-helicase, DNA polymerase α association, and binding of transcription preinitiation complex factors. This abnormal stimulation of the cell cycle is a powerful force for oncogenic transformation.

The small tumor antigen protein is also able to activate several cellular pathways that stimulate cell proliferation. Polyomavirus small T antigens commonly target protein phosphatase 2A (PP2A), a key multisubunit regulator of multiple pathways including Akt, the mitogen-activated protein kinase (MAPK) pathway, and the stress-activated protein kinase (SAPK) pathway. Merkel cell polyomavirus small T antigen encodes a unique domain, called the LT-stabilization domain (LSD), that binds to and inhibits the FBXW7 E3 ligase regulating both cellular and viral oncoproteins. Unlike for SV40, the MCV small T antigen directly transforms rodent cells in vitro.

The middle tumor antigen is used in model organisms developed to study cancer, such as the MMTV-PyMT system where middle T is coupled to the MMTV promoter. There it functions as an oncogene, while the tissue where the tumor develops is determined by the MMTV promoter.

Capsid proteins

The polyomavirus capsid consists of one major component, major capsid protein VP1, and one or two minor components, minor capsid proteins VP2 and VP3. VP1 pentamers form the closed icosahedral viral capsid, and in the interior of the capsid each pentamer is associated with one molecule of either VP2 or VP3. Some polyomaviruses, such as Merkel cell polyomavirus, do not encode or express VP3. The capsid proteins are expressed from the late region of the genome.

Agnoprotein

The agnoprotein is a small multifunctional phospho-protein found in the late coding part of the genome of some polyomaviruses, most notably BK virus, JC virus, and SV40. It is essential for proliferation in the viruses that express it and is thought to be involved in regulating the viral life cycle, particularly replication and viral exit from the host cell, but the exact mechanisms are unclear.

Taxonomy

The polyomaviruses are members of group I (dsDNA viruses). The classification of polyomaviruses has been the subject of several proposed revisions as new members of the group are discovered. Formerly, polyomaviruses and papillomaviruses, which share many structural features but have very different genomic organizations, were classified together in the now-obsolete family Papovaviridae. (The name Papovaviridae derived from three abbreviations: Pa for Papillomavirus, Po for Polyomavirus, and Va for "vacuolating.") The polyomaviruses were divided into three major clades (that is, genetically related groups): the SV40 clade, the avian clade, and the murine polyomavirus clade.

The family contains the following genera:

Description of additional viruses is ongoing. These include the sea otter polyomavirus 1 and Alpaca polyomavirus Another virus is the giant panda polyomavirus 1. Another virus has been described from sigmodontine rodents. Another - tree shrew polyomavirus 1 - has been described in the tree shrew.

Human polyomaviruses

Most polyomaviruses do not infect humans. Of the polyomaviruses cataloged as of 2017, a total of 14 were known with human hosts. However, some polyomaviruses are associated with human disease, particularly in immunocompromised individuals. MCV is highly divergent from the other human polyomaviruses and is most closely related to murine polyomavirus. Trichodysplasia spinulosa-associated polyomavirus (TSV) is distantly related to MCV. Two viruses—HPyV6 and HPyV7—are most closely related to KI and WU viruses, while HPyV9 is most closely related to the African green monkey-derived lymphotropic polyomavirus (LPV).

A fourteenth virus has been described. Lyon IARC polyomavirus is related to raccoon polyomavirus.

List of human polyomaviruses

The following 14 polyomaviruses with human hosts had been identified and had their genomes sequenced as of 2017:

::data[format=table]

SpeciesProposed genusVirus nameAbbreviationNCBI RefSeqYear of discoveryClinical correlate (if any)References
AlphaMerkel cell polyomavirusMCPyVNC_0102772008Merkel cell cancerurl=https://www.nytimes.com/2008/01/18/health/research/18virus.html
AlphaTrichodysplasia spinulosa polyomavirusTSPyVNC_0143612010Trichodysplasia spinulosavauthors = van der Meijden E, Janssens RW, Lauber C, Bouwes Bavinck JN, Gorbalenya AE, Feltkamp MC
AlphaHuman polyomavirus 9HPyV9NC_0151502011None knownvauthors = Scuda N, Hofmann J, Calvignac-Spencer S, Ruprecht K, Liman P, Kühn J, Hengel H, Ehlers B
AlphaHuman polyomavirus 12HPyV12NC_0208902013None knownvauthors = Korup S, Rietscher J, Calvignac-Spencer S, Trusch F, Hofmann J, Moens U, Sauer I, Voigt S, Schmuck R, Ehlers B
AlphaNew Jersey polyomavirusNJPyVNC_0241182014None knownvauthors = Mishra N, Pereira M, Rhodes RH, An P, Pipas JM, Jain K, Kapoor A, Briese T, Faust PL, Lipkin WI
BetaBK polyomavirusBKPyVNC_0015381971Polyomavirus-associated nephropathy; haemorrhagic cystitisvauthors = Gardner SD, Field AM, Coleman DV, Hulme B
BetaJC polyomavirusJCPyVNC_0016991971Progressive multifocal leukoencephalopathyvauthors = Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH
BetaKI polyomavirusKIPyVNC_0092382007None knownvauthors = Allander T, Andreasson K, Gupta S, Bjerkner A, Bogdanovic G, Persson MA, Dalianis T, Ramqvist T, Andersson B
BetaWU polyomavirusWUPyVNC_0095392007None known
DeltaHuman polyomavirus 6HPyV6NC_0144062010vauthors = Nguyen KD, Lee EE, Yue Y, Stork J, Pock L, North JP, Vandergriff T, Cockerell C, Hosler GA, Pastrana DV, Buck CB, Wang RCtitle = Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses
DeltaHuman polyomavirus 7HPyV7NC_0144072010vauthors = Ho J, Jedrych JJ, Feng H, Natalie AA, Grandinetti L, Mirvish E, Crespo MM, Yadav D, Fasanella KE, Proksell S, Kuan SF, Pastrana DV, Buck CB, Shuda Y, Moore PS, Chang Ytitle = Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients
DeltaMW polyomavirusMWPyVNC_0181022012None knownvauthors = Siebrasse EA, Reyes A, Lim ES, Zhao G, Mkakosya RS, Manary MJ, Gordon JI, Wang D
DeltaSTL polyomavirusSTLPyVNC_0201062013None knownvauthors = Lim ES, Reyes A, Antonio M, Saha D, Ikumapayi UN, Adeyemi M, Stine OC, Skelton R, Brennan DC, Mkakosya RS, Manary MJ, Gordon JI, Wang D
Human polyomavirus 14AlphaLyon IARC polyomavirusLIPyVNC_034253.12017None known
::

Deltapolyomavirus contains only the four human viruses shown in the above table. The Alpha and Beta groups contain viruses that infect a variety of mammals. The Gamma group contains the avian viruses.

Antibodies to the monkey lymphotropic polyomavirus have been detected in humans suggesting that this virus - or a closely related virus - can infect humans.

Clinical relevance

All the polyomaviruses are highly common childhood and young adult infections. Most of these infections appear to cause little or no symptoms. These viruses are probably lifelong persistent among almost all adults. Diseases caused by human polyomavirus infections are most common among immunocompromised people; disease associations include BK virus with nephropathy in renal transplant and non-renal solid organ transplant patients, JC virus with progressive multifocal leukoencephalopathy, and Merkel cell virus (MCV) with Merkel cell cancer.

SV40

Main article: SV40

SV40 replicates in the kidneys of monkeys without causing disease, but can cause cancer in rodents under laboratory conditions. In the 1950s and early 1960s, well over 100 million people may have been exposed to SV40 due to previously undetected SV40 contamination of polio vaccine, prompting concern about the possibility that the virus might cause disease in humans. Although it has been reported as present in some human cancers, including brain tumors, bone tumors, mesotheliomas, and non-Hodgkin's lymphomas, accurate detection is often confounded by high levels of cross-reactivity for SV40 with widespread human polyomaviruses.

Diagnosis

The diagnosis of polyomavirus almost always occurs after the primary infection as it is either asymptomatic or sub-clinical. Antibody assays are commonly used to detect presence of antibodies against individual viruses. Competition assays are frequently needed to distinguish among highly similar polyomaviruses.

In cases of progressive multifocal leucoencephalopathy (PML), a cross-reactive antibody to SV40 T antigen (commonly Pab419) is used to stain tissues directly for the presence of JC virus T antigen. PCR can be used on a biopsy of the tissue or cerebrospinal fluid to amplify the polyomavirus DNA. This allows not only the detection of polyomavirus but also which sub type it is.

There are three main diagnostic techniques used for the diagnosis of the reactivation of polyomavirus in polyomavirus nephropathy (PVN): urine cytology, quantification of the viral load in both urine and blood, and a renal biopsy. The reactivation of polyomavirus in the kidneys and urinary tract causes the shedding of infected cells, virions, and/or viral proteins in the urine. This allows urine cytology to examine these cells, which if there is polyomavirus inclusion of the nucleus, is diagnostic of infection. Also as the urine of an infected individual will contain virions and/or viral DNA, quantitation of the viral load can be done through PCR. This is also true for the blood.

Renal biopsy can also be used if the two methods just described are inconclusive or if the specific viral load for the renal tissue is desired. Similarly to the urine cytology, the renal cells are examined under light microscopy for polyomavirus inclusion of the nucleus, as well as cell lysis and viral partials in the extra cellular fluid. The viral load as before is also measure by PCR.

Tissue staining using a monoclonal antibody against MCV T antigen shows utility in differentiating Merkel cell carcinoma from other small, round cell tumors. Blood tests to detect MCV antibodies have been developed and show that infection with the virus is widespread although Merkel cell carcinoma patients have exceptionally higher antibody responses than asymptomatically infected persons.

Use in tracing human migration

The JC virus offers a promising genetic marker for human evolution and migration.{{cite journal | vauthors = Sugimoto C, Kitamura T, Guo J, Al-Ahdal MN, Shchelkunov SN, Otova B, Ondrejka P, Chollet JY, El-Safi S, Ettayebi M, Grésenguet G, Kocagöz T, Chaiyarasamee S, Thant KZ, Thein S, Moe K, Kobayashi N, Taguchi F, Yogo Y |title= Typing of urinary JC virus DNA offers a novel means of tracing human migrations |journal= Proc Natl Acad Sci U S A |date=August 19, 1997 | volume = 94| issue =17 |pages=9191–9196|doi=10.1073/pnas.94.17.9191 |pmid=9256458|pmc=23108|doi-access = free|bibcode= 1997PNAS...94.9191S }} It is carried by 70–90 percent of humans and is usually transmitted from parents to offspring. This method does not appear to be reliable for tracing the recent African origin of modern humans.

History

Murine polyomavirus was the first polyomavirus discovered, having been reported by Ludwik Gross in 1953 as an extract of mouse leukemias capable of inducing parotid gland tumors. The causative agent was identified as a virus by Sarah Stewart and Bernice Eddy, after whom it was once called "SE polyoma". The term "polyoma" refers to the viruses' ability to produce multiple (poly-) tumors (-oma) under certain conditions. The name has been criticized as a "meatless linguistic sandwich" ("meatless" because both morphemes in "polyoma" are affixes) giving little insight into the viruses' biology; in fact, subsequent research has found that most polyomaviruses rarely cause clinically significant disease in their host organisms under natural conditions.

Dozens of polyomaviruses have been identified and sequenced as of 2017, infecting mainly birds and mammals. Two polyomaviruses are known to infect fish, the black sea bass and gilthead seabream. A total of fourteen polyomaviruses are known to infect humans.

References

References

  1. (June 2017). "ICTV Virus Taxonomy Profile: ''Polyomaviridae''". The Journal of General Virology.
  2. "ICTV Report ''Polyomaviridae''".
  3. taxonomy. "Taxonomy browser (''Polyomaviridae'')".
  4. (June 2016). "A taxonomy update for the family ''Polyomaviridae''". Archives of Virology.
  5. (January 2016). "Seroepidemiology of Human Polyomaviruses in a US Population". American Journal of Epidemiology.
  6. (March 2009). "Seroepidemiology of human polyomaviruses". PLOS Pathogens.
  7. (August 2016). "BK virus nephropathy in renal transplant recipients". Nephrology.
  8. (April 2016). "BK polyoma virus infection and renal disease in non-renal solid organ transplantation". Clinical Kidney Journal.
  9. (2015). "Progressive Multifocal Leukoencephalopathy". F1000Research.
  10. (February 2008). "Clonal integration of a polyomavirus in human Merkel cell carcinoma". Science.
  11. (October 2006). "JC virus evolution and its association with human populations". J Virol.
  12. "Viral Zone". ExPASy.
  13. (September 1986). "Self-assembly of purified polyomavirus capsid protein VP1". Cell.
  14. (April 2013). "A cornucopia of human polyomaviruses". Nature Reviews. Microbiology.
  15. (May 2007). "Identification of a novel polyomavirus from patients with acute respiratory tract infections". PLOS Pathogens.
  16. (July 2011). "Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry". PLOS Pathogens.
  17. (2011). "Comparisons between Murine Polyomavirus and Simian Virus 40 Show Significant Differences in Small T Antigen Function". Journal of Virology.
  18. (July 2017). "Merkel Cell Carcinomas Arising in Autoimmune Disease Affected Patients Treated with Biologic Drugs, Including Anti-TNF". Clinical Cancer Research.
  19. (December 2005). "Human polyomaviruses and brain tumors". Brain Research. Brain Research Reviews.
  20. (2014). "Polyomavirus-associated Trichodysplasia spinulosa involves hyperproliferation, pRB phosphorylation and upregulation of p16 and p21". PLOS ONE.
  21. (April 1997). "The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone". Proceedings of the National Academy of Sciences of the United States of America.
  22. (January 1990). "Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A". Cell.
  23. (December 1993). "The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation". Cell.
  24. (November 1996). "Induction of cyclin D1 by simian virus 40 small tumor antigen". Proceedings of the National Academy of Sciences of the United States of America.
  25. (August 2013). "Merkel cell polyomavirus small T antigen controls viral replication and oncoprotein expression by targeting the cellular ubiquitin ligase SCFFbw7". Cell Host & Microbe.
  26. (September 2011). "Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator". The Journal of Clinical Investigation.
  27. (June 1998). "Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry". The EMBO Journal.
  28. (May 2011). "Infection by agnoprotein-negative mutants of polyomavirus JC and SV40 results in the release of virions that are mostly deficient in DNA content". Virology Journal.
  29. (October 2016). "Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses". Journal of Cellular Physiology.
  30. "ICTV Taxonomy Website".
  31. (2013). "IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. Malaria and Some Polyomaviruses (SV40, BK, JC, and Merkel Cell Viruses).". IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.
  32. (June 2006). "Comparing phylogenetic codivergence between polyomaviruses and their hosts". Journal of Virology.
  33. "Virus Taxonomy: 2024 Release". International Committee on Taxonomy of Viruses.
  34. (July 2017). "Endemic infection of stranded southern sea otters (Enhydra lutris nereis) with novel parvovirus, polyomavirus, and adenovirus". Journal of Wildlife Diseases.
  35. (2017). "A novel pulmonary polyomavirus in alpacas (Vicugna pacos)". Veterinary Microbiology.
  36. (2017). "A novel polyomavirus from the nasal cavity of a giant panda (Ailuropoda melanoleuca)". Virology Journal.
  37. (2018). "A novel polyomavirus in sigmodontine rodents from São Paulo State, Brazil". Archives of Virology.
  38. (2019). "Detection and genome characterization of two novel papillomaviruses and a novel polyomavirus in tree shrew (Tupaia belangeri chinensis) in China". Virol J.
  39. (2017). "Isolation and characterization of a novel putative human polyomavirus". Virology.
  40. (September 2009). "Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors". International Journal of Cancer.
  41. (August 2013). "The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications". [[APMIS]].
  42. (May 2011). "A novel human polyomavirus closely related to the african green monkey-derived lymphotropic polyomavirus". Journal of Virology.
  43. (2013). "Identification of a novel human polyomavirus in organs of the gastrointestinal tract". PLOS ONE.
  44. (November 2014). "Identification of a novel polyomavirus in a pancreatic transplant recipient with retinal blindness and vasculitic myopathy". The Journal of Infectious Diseases.
  45. (April 2007). "Identification of a third human polyomavirus". Journal of Virology.
  46. (May 2017). "Human polyomavirus 6 and 7 are associated with pruritic and dyskeratotic dermatoses". Journal of the American Academy of Dermatology.
  47. (June 2010). "Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin". Cell Host & Microbe.
  48. (May 2015). "Human polyomavirus 7-associated pruritic rash and viremia in transplant recipients". The Journal of Infectious Diseases.
  49. (February 2016). "Survey for human polyomaviruses in cancer". JCI Insight.
  50. (October 2012). "Identification of MW polyomavirus, a novel polyomavirus in human stool". Journal of Virology.
  51. (October 2012). "Complete genome sequence of a tenth human polyomavirus". Journal of Virology.
  52. (2012). "Discovery of a novel polyomavirus in acute diarrheal samples from children". PLOS ONE.
  53. (February 2013). "Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing". Virology.
  54. (2017). "Isolation and characterization of a novel putative human polyomavirus". Virology.
  55. (2018). "Human polyomaviruses and cancer: an overview". Clinics (Sao Paulo).
  56. (March 2013). "Human polyomaviruses in disease and cancer". Virology.
  57. (November 2012). "Genome analysis of the new human polyomaviruses". Reviews in Medical Virology.
  58. (March 2009). "Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors". The Journal of Infectious Diseases.
  59. (September 2006). "Is there a role for SV40 in human cancer?". Journal of Clinical Oncology.
  60. (December 2003). "SV40 in human cancers--an endless tale?". International Journal of Cancer.
  61. (December 2002). "SV40 and human tumours: myth, association or causality?". Nature Reviews. Cancer.
  62. (November 2001). "Thirty-five year mortality following receipt of SV40- contaminated polio vaccine during the neonatal period". British Journal of Cancer.
  63. (January 2007). "SV40 and human cancer: a review of recent data". International Journal of Cancer.
  64. (December 2005). "Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods". Human Pathology.
  65. (2006). "Polyomaviruses and Human Diseases".
  66. (January 2000). "Quantification of human polyomavirus JC in brain tissue and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy by competitive PCR". Journal of Virological Methods.
  67. (May 1999). "Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease". Journal of the American Society of Nephrology.
  68. (August 2002). "Quantitation of viral DNA in renal allograft tissue from patients with BK virus nephropathy". Transplantation.
  69. (September 2009). "Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas". The American Journal of Surgical Pathology.
  70. (September 2009). "Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays". International Journal of Cancer.
  71. (September 2009). "Quantitation of human seroresponsiveness to Merkel cell polyomavirus". PLOS Pathogens.
  72. (November 2009). "Association of Merkel cell polyomavirus-specific antibodies with Merkel cell carcinoma". Journal of the National Cancer Institute.
  73. (2012). "DNA for Archaeologists". Routledge.
  74. (June 1953). "A filterable agent, recovered from Ak leukemic extracts, causing salivary gland carcinomas in C3H mice". Proceedings of the Society for Experimental Biology and Medicine.
  75. (June 1958). "Neoplasms in mice inoculated with a tumor agent carried in tissue culture". Journal of the National Cancer Institute.
  76. (November 1959). "Characteristics of the SE polyoma virus". American Journal of Public Health and the Nation's Health.
  77. (July 2011). "Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry". PLOS Pathogens.
  78. (June 2001). "Natural biology of polyomavirus middle T antigen". Microbiology and Molecular Biology Reviews.
  79. (January 2015). "Genome Sequence of a Fish-Associated Polyomavirus, Black Sea Bass (Centropristis striata) Polyomavirus 1". Genome Announcements.
  80. (October 2016). "Concurrence of Iridovirus, Polyomavirus, and a Unique Member of a New Group of Fish Papillomaviruses in Lymphocystis Disease-Affected Gilthead Sea Bream". Journal of Virology.

::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::

polyomaviridaeinfectious-causes-of-cancervirus-families